Maximus (NYSE:MMS) Sets New 1-Year Low – What’s Next?

Maximus, Inc. (NYSE:MMS)’s share price hit a new 52-week low on Monday . The stock traded as low as $60.75 and last traded at $60.9890, with a volume of 185632 shares traded. The stock had previously closed at $64.27.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on MMS shares. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Maximus Stock Down 4.2%

The business has a 50 day simple moving average of $68.82 and a 200 day simple moving average of $80.01. The company has a market capitalization of $3.23 billion, a price-to-earnings ratio of 9.21 and a beta of 0.60. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same period in the previous year, the firm posted $2.01 earnings per share. The company’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities analysts predict that Maximus, Inc. will post 8.33 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. Maximus’s dividend payout ratio is 19.76%.

Insider Activity

In other Maximus news, CEO Bruce Caswell bought 3,175 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were purchased at an average cost of $78.45 per share, with a total value of $249,078.75. Following the purchase, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jan Madsen sold 742 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the sale, the director owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently modified their holdings of the business. Norges Bank acquired a new stake in shares of Maximus in the fourth quarter valued at $60,393,000. River Road Asset Management LLC grew its stake in Maximus by 236.1% during the 4th quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after purchasing an additional 578,326 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in Maximus by 218.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock worth $50,379,000 after purchasing an additional 400,315 shares during the period. Boston Partners increased its holdings in Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after purchasing an additional 308,892 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in Maximus by 493.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock valued at $29,544,000 after purchasing an additional 284,548 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.